A promising cancer drug leads Regeneron to reconsider its aversion to M&A
BioPharma
Source: biopharmadive.com
Page 2 - Checkmate Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Checkmate Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Checkmate Pharmaceutical Today - Breaking & Trending Today
Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) Expected to Announce Earnings of -$0.73 Per Share
Brokerages expect Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI – Get Rating) to report earnings of ($0.73) per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Checkmate Pharmaceuticals’ earnings. Checkmate Pharmaceuticals reported earnings per share of ($0.65) during the same quarter last year, which indicates a negative year-over-year growth rate of […]
Source: etfdailynews.com
10 Pharma Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we examined Mark Lampert’s investment philosophy and decades of experience in the biotechnology space.
Source: insidermonkey.com